526739 Stock Overview
Narmada Gelatines Limited manufactures and sells gelatine and related products in India and internationally.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 5/6 |
Narmada Gelatines Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹381.30 |
52 Week High | ₹517.95 |
52 Week Low | ₹287.50 |
Beta | 0.34 |
1 Month Change | 7.70% |
3 Month Change | -13.24% |
1 Year Change | 21.34% |
3 Year Change | 147.76% |
5 Year Change | 196.04% |
Change since IPO | 1,351.65% |
Recent News & Updates
Recent updates
Shareholder Returns
526739 | IN Chemicals | IN Market | |
---|---|---|---|
7D | -2.8% | -2.5% | -2.5% |
1Y | 21.3% | 17.2% | 44.5% |
Return vs Industry: 526739 exceeded the Indian Chemicals industry which returned 17.4% over the past year.
Return vs Market: 526739 underperformed the Indian Market which returned 45.3% over the past year.
Price Volatility
526739 volatility | |
---|---|
526739 Average Weekly Movement | 5.9% |
Chemicals Industry Average Movement | 6.4% |
Market Average Movement | 6.9% |
10% most volatile stocks in IN Market | 10.1% |
10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: 526739 has not had significant price volatility in the past 3 months.
Volatility Over Time: 526739's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1961 | 201 | Ashok Kapur | www.narmadagelatines.com |
Narmada Gelatines Limited manufactures and sells gelatine and related products in India and internationally. The company’s products include ossein and di-calcium phosphate. It serves food and beverage, pharmaceutical, photography, biomedical, personal care, and other technical industries.
Narmada Gelatines Limited Fundamentals Summary
526739 fundamental statistics | |
---|---|
Market cap | ₹2.31b |
Earnings (TTM) | ₹150.43m |
Revenue (TTM) | ₹1.82b |
15.3x
P/E Ratio1.3x
P/S RatioIs 526739 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
526739 income statement (TTM) | |
---|---|
Revenue | ₹1.82b |
Cost of Revenue | ₹1.39b |
Gross Profit | ₹427.11m |
Other Expenses | ₹276.68m |
Earnings | ₹150.43m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 15, 2024
Earnings per share (EPS) | 24.87 |
Gross Margin | 23.44% |
Net Profit Margin | 8.26% |
Debt/Equity Ratio | 0% |
How did 526739 perform over the long term?
See historical performance and comparison